Piperazine

Piperazine

SCHEMBL28080505

C1CNCCN1.CS(=O)(=O)N1CCNCC1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
MAPT P10636 1/20 0.39
ALDH1A1 P00352 3/20 0.39
NEK2 P51955 1/20 0.37
KMT2A Q03164 3/20 0.37
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
USP2 O75604 1/20 0.36
PKM P14618 1/20 0.35
IKBKB O14920 1/20 0.35
CYP2D6 P10635 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8742086 1.00 KDM4E (0.50) KDM4EMAPTALDH1A1NEK2KMT2A
SCHEMBL5013 0.97 KDM4E (0.52) KDM4EMAPTALDH1A1NEK2KMT2A
SCHEMBL477197 0.97 KDM4E (0.52) KDM4EMAPTALDH1A1NEK2KMT2A
Potassium SCHEMBL30601760 0.95 KDM4E (0.50) KDM4EMAPTALDH1A1NEK2KMT2A
Hydrochloric Acid SCHEMBL311054 0.95 KDM4E (0.50) KDM4EMAPTALDH1A1NEK2KMT2A
SCHEMBL21040872 0.91 KDM4E (0.54) KDM4EMAPTALDH1A1KMT2ALMNA
Methylene Chloride SCHEMBL16447276 0.88 KDM4E (0.45) KDM4EMAPTALDH1A1NEK2KMT2A
Piperidine SCHEMBL28145582 0.88 KDM4E (0.56) KDM4EMAPTALDH1A1NEK2KMT2A
SCHEMBL92545 0.88 KDM4E (0.56) KDM4EMAPTALDH1A1NEK2KMT2A
Hydrochloric Acid SCHEMBL189869 0.86 KDM4E (0.54) KDM4EMAPTALDH1A1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641886-A bicyclic BET bromodomain inhibitors and uses thereof 康威基内有限公司 2019-04-16 CN disclosed
CN-105814022-B Condensed bicyclic heteroaromatic derivative as TNF active regulators UCB生物制药私人有限公司 2018-09-28 CN disclosed
CN-105189515-B Furopyridine class as bromine structural domain inhibitor 葛兰素史克知识产权第二有限公司 2018-07-03 CN disclosed
CN-105814046-B Imidazopyridine derivatives as TNF active regulators UCB生物制药私人有限公司 2018-01-30 CN disclosed
CN-105814045-B Imidazopyridine derivatives as modulators of TNF activity UCB生物制药私人有限公司 2017-08-25 CN disclosed
CN-104470924-B Imidazopyrazines derivant as TNF active regulator UCB生物制药私人有限公司 2016-11-09 CN disclosed
CN-105814045-A Imidazopyridine derivatives as modulators of TNF activity UCB生物制药私人有限公司 2016-07-27 CN disclosed
CN-105814046-A Imidazopyridine derivatives as modulators of TNF activity UCB生物制药私人有限公司 2016-07-27 CN disclosed
CN-1922175-A As 5-HT4Indazole-carboxamide compounds as receptor agonists THERAVANCE INC (US) 2007-02-28 CN disclosed